Both systems’ boards have approved the deal, but it still requires final regulatory approval. The transaction is expected to close in late 2015.
Through the deal, SRHS will benefit from UH’s technology and strong clinical research. UH will invest in making upgrades to SRHS’ facilities, equipment, services and technologies.
Commenting on the deal, CEO of University Hospitals Thomas F. Zenty III said, “We and Samaritan’s leadership are enthused about the new possibilities we’re creating.”
More articles on healthcare industry transactions:
6 recent hospital transactions and partnerships
Bankrupt Maine hospital merges with Mid Coast Health
Lafayette General Health to acquire hospital from HCA
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
